Kezar Life Sciences, Inc. (NASDAQ: KZR) reported Q1 EPS of ($0.30), $0.05 better than the analyst estimate of ($0.35).

For earnings history and earnings-related data on Kezar Life Sciences, Inc. (KZR) click here.